The neuraminidase inhibitor GS4104 (oseltamivir phosphate) is efficacious against A/Hong Kong/156/97 (H5N1) and A/Hong Kong/1074/99 (H9N2) influenza viruses

Antiviral Research

Volumn 48, Issue 2, 2000, Pages 101-115

  Leneva, Irina A ^a,b   Roberts, Noel ^c   Govorkova, Elena A ^a,d   Goloubeva, Olga G ^a   Webster, Robert G ^a,e  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^b Russian Chemical and Pharmaceutical Institute   (Russian Federation)

^c ROCHE PRODUCTS LTD   (United Kingdom)

^d D I IVANOVSKY INSTITUTE OF VIROLOGY   (Russian Federation)

^e UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

Antiviral agents; Avian influenza viruses; Human influenza A viruses

Indexed keywords

4 ACETAMIDO 5 AMINO 3 (1 ETHYLPROPOXY) 1 CYCLOHEXENE 1 CARBOXYLIC ACID; OSELTAMIVIR; RIMANTADINE; SIALIDASE INHIBITOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL STRAIN; CONTROLLED STUDY; DRUG EFFICACY; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; INFLUENZA; INFLUENZA VIRUS; INFLUENZA VIRUS A; MOUSE; NONHUMAN; PATHOGENICITY; PRIORITY JOURNAL; VIRUS REPLICATION; VIRUS TITRATION;

ACETAMIDES; ANIMALS; ANTIVIRAL AGENTS; BRAIN; CELL LINE; DOGS; ENZYME INHIBITORS; FEMALE; HUMANS; INFLUENZA A VIRUS; INFLUENZA A VIRUS, H5N1 SUBTYPE; INFLUENZA A VIRUS, H9N2 SUBTYPE; INFLUENZA, HUMAN; KIDNEY; LUNG; MICE; MICE, INBRED BALB C; NEURAMINIDASE; OSELTAMIVIR; RIMANTADINE; VIRUS REPLICATION;

AVES; AVIAN INFLUENZA VIRUS; INFLUENZA A VIRUS; INFLUENZA VIRUS; PHASIANIDAE;

EID: 0033651178     PISSN: 01663542     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0166-3542(00)00123-6     Document Type: Article

References (43)

1. The neuraminidase of influenza virus
2. Influenza virus neuraminidase-inhibition test procedures
3. Neuraminidase inhibitors as potential anti-influenza drugs
4. Genetic basis of resistance to rimantadine emerging during treatment of influenza virus infection
5. Human influenza A H5N1 virus related to a highly pathogenic avian influenza virus
6. A pandemic warning?
7. Distinct pathogenesis of Hong Kong-origin H5N1 viruses in mice compared to that of other highly pathogenic H5 avian influenza viruses
8. Prophylaxis and treatment of influenza
9. Biological heterogeneity, including systemic replication in mice, of H5N1 influenza A virus isolates from humans in Hong Kong
10. The in vivo antiviral activity of 1-adamantanamine (amantadine)
11. Molecular characterization of H9N2 influenza viruses: Were they the donors of the 'internal' genes of H5N1 viruses in Hong Kong?
12. Inhibition of replication of avian influenza viruses by the neuraminidase inhibitor 4-guanidino-2,4-dideoxy-2,3-dehydro-N-acetylneuraminic acid
13. Characterization of mutants of influenza A virus selected with the neuraminidase inhibitors 4-guanidino-neu5Ac2en
14. Characterization of influenza A/Hong Kong/156/97 (H5N1) virus in mouse model and protective effect of zanamivir on H5N1 infection in mice
15. Neuraminidase inhibitors: new candidate drugs for influenza
16. Influenza virus neuraminidase inhibitors
17. Amantadine and rimantadine - mechanisms
18. Anti-influenza virus activity of the compound LY253963
19. Clinical and epidemiological importance of influenza A virus resistant to amantadine and rimantadine
20. Amantadine and rimantadine-clinical aspects
21. Safety and efficacy of the neuraminidase inhibitor GG167 in experimental human influenza
22. In vitro activity of neuraminidase inhibitor GS 4107 against influenza viruses
23. Rational design of potent sialidase-based inhibitors of influenza virus protection
24. First International Symposium on Influenza and Other Respiratory Viruses: Summary and Overview: Kapalua, Maui, Hawaii, 4-6 December
25. Efficacy of GS4104 in ferrets infected with influenza virus
26. GS4104 is a highly bioavailable prodrug of the novel, potent influenza neuraminidase inhibitor GS 4107
27. A mouse model for the evaluation of pathogenesis and immunity to influenza A (H5N1) viruses isolated from humans
28. Mutation in the influenza virus neuraminidase gene resulting in decreased sensitivity to the neuraminidase inhibitor 4-guanidino-neu5Ac2en leads to instability of the enzyme
29. GS4071 is a potent and selective inhibitor of the growth and neuraminidase activity of influenza A and B viruses in vitro
30. Oral administration of a prodrug of the influenza virus neuraminidase inhibitor GS4071 protects mice and ferrets against influenza infection
31. Effectiveness of inactivated influenza vaccine among nursing home residents during an influenza type A(H3N2) epidemic
32. Inhibition of influenza virus replication in tissue culture by 2-deoxy-2,3-dehydro-N-trifluoroacetylneuraminic acid (FANA): mechanism action
33. Human infection with influenza H9N2
34. Chronicle of influenza pandemics
35. Effect of age on cytotoxic T lymphocyte memory as well as serum and local antibody responses elicited by inactivated influenza virus vaccine
36. Now and future influenza vaccines
37. Inhibition of influenza virus infections in mice by GS4104, an orally effective influenza virus neuraminidase inhibitor
38. Characterization of an avian influenza A (H5N1) virus isolated from child with fatal respiratory illness
39. Characterization of human influenza virus variants selected in vitro in the presence of the neuraminidase inhibitor GS4071
40. Acute encephalitis and encephaty at the height of influenza in childhood
41. Inhibition of the growth of influenza viruses in vitro by 4-guanidino-2,4-dideoxy-N-acetylneuraminic acid
42. 4-guanidino-2,4-dideoxy-2,3-dehydro-N-acethylneuraminic acid is a highly effective inhibitor both of the sialidase (neuraminidase) and of growth of wide range of influenza A and B viruses in vitro
43. Study of rimanatadine in the USSR: a review of the literature